Norwich, United Kingdom · Founded 2018 · Privately Held (backing)
Operator of a gene therapy company intended to treat common eye diseases. Ikarovec is based in Norwich, United Kingdom and was founded in 2018. Its last known valuation is $184 million. It has raised $43.9 million.
Last price · $/share
—
Implied valuation
$184.0M
Total raised
$43.9M
Last round
—
Team — not yet on record
No current team members for Ikarovec are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ikarovec with a free account
·Watch Ikarovec: the Monday email on marks, rounds and moves
